4418-57-9

Basic information

• Product Name: 5-ETHYL-4-METHYL-4 H-[1,2,4]TRIAZOLE-3-THIOL
• Synonyms: ART-CHEM-BB B015689;CHEMBRDG-BB 3015689;AKOS B015689;5-ETHYL-4-METHYL-4 H-[1,2,4]TRIAZOLE-3-THIOL;5-ethyl-4-methyl-4H-1,2,4-triazole-3-thiol(SALTDATA: FREE);5-ethyl-4-methyl-2H-1,2,4-triazole-3-thione
• CAS NO: 4418-57-9
• Molecular Formula: C₅H₉N₃S
• Molecular Weight: 143.21
• Mol File: 4418-57-9.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 173°C at 760 mmHg
• Flash Point: 58.4°C
• Appearance: /
• Density: 1.28g/cm³
• Vapor Pressure: 1.3mmHg at 25°C
• Refractive Index: 1.638
• CAS DataBase Reference: 5-ETHYL-4-METHYL-4 H-[1,2,4]TRIAZOLE-3-THIOL(CAS DataBase Reference)
• NIST Chemistry Reference: 5-ETHYL-4-METHYL-4 H-[1,2,4]TRIAZOLE-3-THIOL(4418-57-9)
• EPA Substance Registry System: 5-ETHYL-4-METHYL-4 H-[1,2,4]TRIAZOLE-3-THIOL(4418-57-9)

Safety Data

• Hazard Codes: Xi
• HazardClass: IRRITANT
• Hazardous Substances Data: 4418-57-9(Hazardous Substances Data)

Usage

General Description

5-ETHYL-4-METHYL-4 H-[1,2,4]TRIAZOLE-3-THIOL is a heterocyclic compound that contains a triazole ring and a thiol group. It is characterized by the presence of an ethyl and a methyl group on the triazole ring. 5-ETHYL-4-METHYL-4 H-[1,2,4]TRIAZOLE-3-THIOL has potential applications in the field of pharmaceuticals, agrochemicals, and materials science due to its diverse chemical properties. It may also exhibit biological activities such as antimicrobial, antiviral, and anticancer properties. Further research and testing are necessary to fully understand and unlock the potential of 5-ETHYL-4-METHYL-4 H-[1,2,4]TRIAZOLE-3-THIOL.

InChI:InChI=1/C5H9N3S/c1-3-4-6-7-5(9)8(4)2/h3H2,1-2H3,(H,7,9)

Relevant articles and documents

COMPOUNDS FOR MODULATING AQUAPORINS

The invention relates to compounds of formula (I) pharmaceutical compositions thereof and methods for modulating aquaporin 9.

TRIAZOLE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULAIONT OF THE DOPAMINE D3 RECEPTOR

The invention relates to compounds of formula (I), wherein n is 1 or 2, Ar is a C-bound 1,2,4-triazol radical which carries a radical R1 on the remaining carbon atom and a radical R1a on one of the nitrogen atoms; R1 is hydrogen, C1-C6 alkyl, C3-C6 cycloalkyl, C1-C4 alkoxymethyl, fluorinated C1-C6 alkyl, fluorinated C3-C6 cycloalkyl, fluorinated C1-C4 alkoxymethyl, or optionally substituted phenyl or 5- or 6-membered heteroaryl; R1a is hydrogen or C1-C4 alkyl; and R2 is C1-C6 alkyl, C3-C6 cycloalkyl, fluorinated C1-C6 alkyl or fluorinated C3-C6 cycloalkyl; and to the physiologically tolerated acid addition salts of there compounds. The invention also relates to a pharmaceuticaly composition that comprises at least one triazole compound of the formula (I) and/or at least one physiologically tolerated acid addition salt thereof, and further to a method for treating disorders that respond beneficially to dopamine D3 receptor antagonists or dopamine D3 agonists, said method comprising administering an effective amount of at least one traizole compound or physiologically tolerated acid addition salt of the formula (I) to a subject in need thereof.